Literature DB >> 6110768

The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits.

R J Beninger, S T Mason, A G Phillips, H C Fibiger.   

Abstract

Three groups (N = 8) of rats received five 10-trial sessions of one-way avoidance training in which each trial was initiated by a 10-sec tone stimulus and terminated either by a shuttle response during the tone (avoidance) or by a response during the electric shock (escape). Rats in groups treated with pimozide (0.5 or 1.0 mg/kg i.p.) failed to acquire to avoidance response although they escaped readily when shock was presented, whereas control rats consistently avoided the shock. The same rats then received several sessions of food-reinforced lever-pressing in a different apparatus; no drugs were given during these sessions. When responding had stabilized, the tone that had signalled shock in the avoidance sessions was presented for a 1-min period. A significant decrease in responding during the tone was observed in all groups when compared to unshocked controls, demonstrating that the pimozide-treated rats, although failing to acquire the avoidance response in the shuttle box, had learned the association between the tone and shock. The results suggested that the neuroleptic-treated animals failed to avoid because of a deficit in the ability to initiate responses rather than a deficit in associative learning.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110768

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

Review 1.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

2.  Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence.

Authors:  James M Gold; James A Waltz; Tatyana M Matveeva; Zuzana Kasanova; Gregory P Strauss; Ellen S Herbener; Anne G E Collins; Michael J Frank
Journal:  Arch Gen Psychiatry       Date:  2012-02

3.  Two-factor theory, the actor-critic model, and conditioned avoidance.

Authors:  Tiago V Maia
Journal:  Learn Behav       Date:  2010-02       Impact factor: 1.986

4.  Roles of D1-like dopamine receptors in the nucleus accumbens and dorsolateral striatum in conditioned avoidance responses.

Authors:  Evellyn Claudia Wietzikoski; Suelen Lúcio Boschen; Edmar Miyoshi; Mariza Bortolanza; Lucélia Mendes Dos Santos; Michael Frank; Marcus Lira Brandão; Philip Winn; Claudio Da Cunha
Journal:  Psychopharmacology (Berl)       Date:  2011-07-01       Impact factor: 4.530

5.  The use of extinction to investigate the nature of neuroleptic-induced avoidance deficits.

Authors:  R J Beninger; S T Mason; A G Phillips; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  Response decrement patterns after neuroleptic and non-neuroleptic drugs.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.

Authors:  Min Feng; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

8.  How do tranquilizing agents selectively inhibit conditioned avoidance responding?

Authors:  D M Grilly; S K Johnson; R Minardo; D Jacoby; J LaRiccia
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 9.  A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.

Authors:  Jennifer M Wenzel; Noah A Rauscher; Joseph F Cheer; Erik B Oleson
Journal:  ACS Chem Neurosci       Date:  2014-12-24       Impact factor: 4.418

10.  Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems.

Authors:  A Ettenberg; H O Pettit; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.